Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2017 08:30 ET | Source: Evoke Pharma

Evoke Pharma to Attend 2017 JPMorgan Healthcare Conference

SOLANA BEACH, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
January 04, 2017 08:30 ET | Source: Evoke Pharma

Evoke Provides Additional Data Demonstrating Statistically Significant Benefit for Gimoti in Moderate to Severe Patients in Phase 3 Diabetic Gastroparesis Trial

SOLANA BEACH, CA, Jan. 04, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today provided...
December 15, 2016 16:08 ET | Source: Evoke Pharma

Evoke Receives Positive NDA Submission Guidance from US FDA for Gimoti

SOLANA BEACH, Calif., Dec. 15, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
November 09, 2016 16:05 ET | Source: Evoke Pharma

Evoke Pharma Reports Third Quarter 2016 Results

SOLANA BEACH, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
November 01, 2016 08:30 ET | Source: Evoke Pharma

Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2016 Financial Results

SOLANA BEACH, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
September 07, 2016 08:30 ET | Source: Evoke Pharma

Evoke Pharma Announces Positive Non-Clinical Pre-NDA Meeting with FDA for Gimoti

SOLANA BEACH, Calif., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK) (the “Company"), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases,...
September 06, 2016 16:15 ET | Source: Evoke Pharma

Evoke Pharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference

SOLANA BEACH, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
August 15, 2016 16:31 ET | Source: Evoke Pharma

Evoke Pharma Reports Second Quarter 2016 Results

SOLANA BEACH, Calif., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK) (the “Company"), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases,...
August 10, 2016 08:30 ET | Source: Evoke Pharma

Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2016 Financial Results

SOLANA BEACH, Calif., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
August 08, 2016 08:30 ET | Source: Evoke Pharma

Evoke Pharma Completes Credit Facility Repayment

SOLANA BEACH, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK) (the “Company"), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI)...